← Leaderboards
Kathleen A Neville
Children'S Mercy Hosp (Kansas City, Mo)
$756,586
Attributed
$756,586
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $154.2K · FY2006–10$200K$150K$100K$50K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$756,586 · 1
By mechanism
K23$756,586 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Mercy Hosp (Kansas City, Mo)
Same institution · by research overlap
- James Steven Leeder$15,267,008
- Bridgette L. Jones$4,441,214
- Jennifer Lynn Goldman$4,709,020
- William E Truog$2,504,970
- Gregory L Kearns$5,962,932
Others in their field
Top investigators on “Complication”
- Constance Ann Benson · University Of California, San Diego$275,646,352
- Chanza Baytop · Westat, Inc.$271,217,917
- James Dennis Neaton · Northwestern University$203,539,316
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$198,115,770
- Carol Nesel · Westat$188,148,170
- David M Nathan · Massachusetts Institute Of Technology$165,583,589
Research focus
ComplicationConsumptionAcetylcholineComplementBasic ScienceAnalgesicsBiologyAffectAreaBlood VesselsCandidate Disease GeneCareerCaringCell PhysiologyChildChildhoodClinicClinical InvestigatorBlood FlowClinical ResearchClinical Research Curriculum AwardClinical TrialsCollaborationsCytosol
Grant awards (5)
Pharmacogenetics of Pediatric Sickle Cell Disease$142,012
K23 · FY2010 · HL · contact PI
Pharmacogenetics of Pediatric Sickle Cell Disease$153,792
K23 · FY2009 · HL · contact PI
Pharmacogenetics of Pediatric Sickle Cell Disease$154,022
K23 · FY2008 · HL · contact PI
Pharmacogenetics of Pediatric Sickle Cell Disease$154,237
K23 · FY2007 · HL · contact PI
Pharmacogenetics of Pediatric Sickle Cell Disease$152,523
K23 · FY2006 · HL · contact PI